Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Editorial Volume 4 Issue 2

Transforming A Coronavirus Protein into A Nanoparticle for Production of Promising COVID-19 Vaccine

Porntep Siriwanarangsun1, Attapon Cheepsattayakorn1,2* and Ruangrong Cheepsattayakorn3

1Faculty of Medicine, Western University, Pathumtani Province, Thailand
210th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.

Received: November 28, 2020; Published: December 22, 2020

×

  In the mid-1960s, coronavirus were found that it can infect both humans and animals (birds and mammals), whereas novel coronavirus-2019 (2019-nCoV or COVID-19) with closed relation to SARS-CoV was first identified from a patient with pneumonia, related to the cluster of acute respiratory illness cases from Wuhan, China. Presently, there is no best vaccine to end the COVID-19 pandemic.

×

References

×

Citation

Citation: Attapon Cheepsattayakorn., et al. “Transforming A Coronavirus Protein into A Nanoparticle for Production of Promising COVID-19 Vaccine". Acta Scientific Microbiology 4.2 (2021): 01.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US